Tags

Type your tag names separated by a space and hit enter

Safety, tolerability, and efficacy of orally administered cannabinoids in MS.

Links

  • Publisher Full Text
  • Authors

    Source

    Neurology 60:4 2003 Feb 25 pg 729-30; author reply 729-30

    MeSH

    Administration, Oral
    Affect
    Appetite
    Cannabidiol
    Cannabinoids
    Cannabis
    Clinical Trials, Phase III as Topic
    Double-Blind Method
    Dronabinol
    Humans
    Multiple Sclerosis
    Muscle Spasticity
    Neuralgia
    Plant Extracts
    Reflex, Abnormal
    Safety
    Sleep
    Switzerland
    Treatment Outcome
    United Kingdom

    Pub Type(s)

    Letter
    Comment

    Language

    eng

    PubMed ID

    12601130

    Citation

    Russo, Ethan B.. "Safety, Tolerability, and Efficacy of Orally Administered Cannabinoids in MS." Neurology, vol. 60, no. 4, 2003, pp. 729-30; author reply 729-30.
    Russo EB. Safety, tolerability, and efficacy of orally administered cannabinoids in MS. Neurology. 2003;60(4):729-30; author reply 729-30.
    Russo, E. B. (2003). Safety, tolerability, and efficacy of orally administered cannabinoids in MS. Neurology, 60(4), pp. 729-30; author reply 729-30.
    Russo EB. Safety, Tolerability, and Efficacy of Orally Administered Cannabinoids in MS. Neurology. 2003 Feb 25;60(4):729-30; author reply 729-30. PubMed PMID: 12601130.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Safety, tolerability, and efficacy of orally administered cannabinoids in MS. A1 - Russo,Ethan B, PY - 2003/2/26/pubmed PY - 2004/1/30/medline PY - 2003/2/26/entrez SP - 729-30; author reply 729-30 JF - Neurology JO - Neurology VL - 60 IS - 4 SN - 1526-632X UR - https://www.unboundmedicine.com/medline/citation/12601130/Safety_tolerability_and_efficacy_of_orally_administered_cannabinoids_in_MS_ L2 - http://www.neurology.org/cgi/pmidlookup?view=long&pmid=12601130 DB - PRIME DP - Unbound Medicine ER -